ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK/ERK

Bo Sun1, Fang-Jing Zhong1

  • 1Department of Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.

Abstract

Insights

Epidermal growth factor, latrophilin and seven-transmembrane domain-containing 1 (ELTD1) promotes gastric cancer (GC) metastasis by activating MAPK/ERK signaling and inhibiting CSK. High ELTD1 expression predicts poor prognosis in GC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Gastric cancer (GC) metastasis remains a primary cause of patient mortality.
  • The molecular mechanisms driving GC metastasis are complex and not fully understood.
  • Epidermal growth factor, latrophilin and seven-transmembrane domain-containing 1 (ELTD1) has been implicated in cancer metastasis, but its role in GC is unexplored.

Purpose of the Study:

  • To investigate the expression and function of ELTD1 in gastric cancer.
  • To elucidate the molecular mechanism by which ELTD1 influences GC progression.
  • To evaluate ELTD1 as a prognostic biomarker for GC patients.

Main Methods:

  • ELTD1 expression analysis in GC tissues and public databases (TCGA, Oncomine, GEO).
  • In vitro and in vivo experiments to assess the effects of ELTD1 on GC cell proliferation, migration, invasion, and metastasis.
  • Investigation of ELTD1's mechanism of action, including its interaction with C-terminal Src kinase (CSK) and its effect on MAPK/ERK signaling.
  • Correlation analysis between ELTD1 expression and overall survival in GC patients.

Main Results:

  • ELTD1 is significantly upregulated in GC tissues.
  • ELTD1 knockdown inhibits GC cell proliferation, migration, invasion, tumor growth, and metastasis, while overexpression has opposite effects.
  • ELTD1 promotes epithelial to mesenchymal transition (EMT) by activating MAPK/ERK signaling through inhibition of CSK.
  • High ELTD1 expression is associated with poorer prognosis in GC patients, and the combination of ELTD1 and CSK improves predictive performance.

Conclusions:

  • ELTD1 functions as an oncogene in GC by promoting metastasis via the MAPK/ERK signaling pathway through CSK inhibition.
  • ELTD1 represents a potential prognostic predictor and therapeutic target for gastric cancer.
  • Targeting ELTD1 may offer a novel strategy for managing GC metastasis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K